Alkem Laboratories shares fall 2.02% in Wednesday's trading session

Shares of Alkem Laboratories declined by 2.02% to trade at Rs 4,821.50 in Wednesday's session. The stock is a constituent of the Nifty Midcap 150 index.

In related corporate actions, the company has scheduled a conference call on August 12, 2025, at 4:30 p.m. to discuss the Q1 FY26 financial results. Additionally, a board meeting is scheduled for August 12, 2025, to consider and approve the standalone and consolidated unaudited financial results for the quarter ending June 30, 2025.

Recent Financial Performance:Alkem Laboratories' recent financial performance shows the following trends based on consolidated quarterly data:

• Revenue: The company's revenue has fluctuated over the past five quarters, with a recent figure of Rs 3,143.75 Crore for the quarter-ending March 2025.
• Net Profit: Net profit also varied, with Rs 323.01 Crore reported for the quarter-ending March 2025.
• EPS: Earnings per share stood at Rs 25.57 for the quarter-ending March 2025.

HeadingMar 2024Jun 2024Sep 2024Dec 2024

Mar 2025RevenueRs 2,935.82 CroreRs 3,031.82 CroreRs 3,414.67 CroreRs 3,374.28 Crore

Rs 3,143.75 CroreNet ProfitRs 304.48 CroreRs 550.24 CroreRs 701.96 CroreRs 640.79 Crore

Rs 323.01 CroreEPS24.5545.6057.6052.34

25.57

Annual Consolidated Financials:The yearly financial performance provides the following insights:

• Revenue: There has been a steady increase in revenue over the years, with Rs 12,964.52 Crore reported for the year-ending March 2025.
• Net Profit: Net profit has also increased, reaching Rs 2,216.00 Crore for the year-ending March 2025.
• EPS: The Earnings Per Share (EPS) has risen to Rs 181.11 for the year-ending March 2025.

Heading2021202220232024

2025RevenueRs 8,865.01 CroreRs 10,634.19 CroreRs 11,599.26 CroreRs 12,667.58 Crore

Rs 12,964.52 CroreNet ProfitRs 1,617.77 CroreRs 1,680.32 CroreRs 1,006.81 CroreRs 1,811.46 Crore

Rs 2,216.00 CroreEPS132.57137.6382.31150.19

181.11BVPS632.20740.05789.21896.23

1,002.50ROE21.4819.0510.8817.41

18.06Debt to Equity0.230.300.140.12

0.09

The revenue for the year ending March 2025 increased by 2.34% compared to the year ending March 2024. Net profit for the year ending March 2025 also increased by 22.33% compared to the previous year.

Alkem Laboratories announced a final dividend of Rs 8 per share (400%) with an effective date of August 8, 2025. Prior to this, an interim dividend of Rs 37 per share (1850%) was announced on January 28, 2025, with an effective date of February 14, 2025.The stock is trading on the Nifty Midcap 150 index.